Polaprezinc Impurity 5 is a related peptide-zinc complex variant formed during polaprezinc synthesis or degradation. Changes in metal coordination alter spectral features and retention profiles. Researchers characterize its metal-binding geometry and stability. Applications include impurity mapping, coordination-chemistry studies, and analytical specificity development.
CAT No: Z10-101-179
Synonyms/Alias:(S)-2-((3-((1-carboxylato-2-(1H-imidazol-4-yl)ethyl)amino)-3-oxopropyl)carbamoyl)benzoate
Polaprezinc Impurity 5 is a structurally defined organic compound classified as a pharmaceutical impurity, specifically associated with the synthesis and quality assessment of polaprezinc. As a chemically distinct byproduct or degradation product formed during the manufacture or storage of polaprezinc, this impurity holds significant relevance in analytical chemistry and pharmaceutical research. Its precise identification and characterization are critical for ensuring the quality, consistency, and safety of polaprezinc-based formulations. The availability of Polaprezinc Impurity 5 as a reference standard enables laboratories and researchers to comply with stringent analytical requirements and to advance the understanding of impurity profiles in complex pharmaceutical matrices.
Analytical method development: Polaprezinc Impurity 5 serves as an essential reference standard for the development and validation of analytical methods such as high-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), and related techniques. By providing a well-characterized impurity, it allows researchers to establish accurate retention times, optimize detection parameters, and assess method specificity and sensitivity. This is crucial for distinguishing the impurity from the parent compound and other related substances, thereby supporting robust quality control protocols in pharmaceutical production.
Impurity profiling and identification: The compound plays a pivotal role in impurity profiling studies, which are fundamental to pharmaceutical development and regulatory compliance. Its inclusion in forced degradation and stability testing protocols enables the identification and quantification of trace-level impurities in polaprezinc formulations. By understanding the presence and behavior of such impurities, researchers can elucidate degradation pathways, assess product stability, and refine manufacturing processes to minimize impurity formation.
Reference material for quality control: Laboratories engaged in routine quality assurance rely on well-defined impurity standards like Polaprezinc Impurity 5 to calibrate analytical instruments and validate batch-to-batch consistency. The presence of this impurity standard facilitates the accurate quantification of impurity levels in finished products, ensuring that pharmaceutical formulations meet established quality benchmarks. This practice is integral to maintaining the integrity of the supply chain and supporting regulatory submissions.
Pharmaceutical research and process optimization: The study of process-related impurities such as this one informs the optimization of synthetic routes and purification strategies in pharmaceutical manufacturing. By monitoring the formation and removal of Polaprezinc Impurity 5 during process development, scientists can identify critical control points and implement improvements that enhance product yield and purity. This contributes to more efficient and sustainable manufacturing practices while reducing the risk of unwanted byproducts.
Structural elucidation and mechanistic studies: The availability of isolated and characterized impurity standards underpins structural elucidation efforts using techniques like nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry. Detailed analysis of Polaprezinc Impurity 5 provides insights into its chemical structure, formation mechanisms, and potential reactivity under various conditions. Such knowledge not only supports regulatory documentation but also advances the broader scientific understanding of impurity chemistry in pharmaceutical systems.
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More